The company's CoverScan MD software helps in the assessment of heart, liver, lungs, kidneys, pancreas, and spleen -- all with one scan rather than multiple tests, according to the company. It is thought that up to 30% of people infected with SARS-CoV-2 and who are symptomatic have "long COVID," that is, with effects that last longer than 12 weeks.

A variety of organs are vulnerable to underlying and long-lasting damage, which can be visualized on imaging studies. Perspectum is positioning CoverScan MD as a "one-stop shop" for long COVID detection.